Australia's largest stock trading and investment forum Australia's #1 stock forum

CGL

Click for more information

0.00%

$5.49 the citadel group limited

Ann: Citadel Group FY18 Financial Results, page-10

First 10 Last

Share
Profile

Follow
avagadro

13,166 Posts.

1275

13/09/18

11:00

Post #: 35570681
Share

Originally posted by TitusPullo ↑

BP updated yesterday, a couple of snips

"Becoming more like Technology One and Pro Medicus
Citadel is currently transitioning from a managed services provider to more of a software and services company and the recent result suggests this change is gaining traction. We believe the company now has characteristics similar to other software and services companies such as Technology One (TNE) and Pro Medicus (PME). For instance, Citadel has secured part of the Brisbane City Council (BCC) contract which Technology One originally won but then lost over a contract dispute. Also, the company is now taking Charm – the leading oncology e-Health system in Australia – offshore and so is starting to look more like what Pro Medicus is doing in radiology. Interestingly, however, the FY19 PE ratio of Citadel is much lower than that of Technology One and Pro Medicus (i.e. 22x vs 30x and 66x) and so this suggests to us that the current re-rating of the Citadel multiple could still have some way to go."

"Investment view: PT up 6% to $9.00, Maintain BUY"

Expand

Totally agree. Re-rate on this incoming. Whether it takes price coverage or a financial update is irrelevant to me

CGL Price at posting: $7.83 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

First 10 Last

Add CGL (ASX) to my watchlist